Morgan Stanley raised the firm’s price target on Nasdaq (NDAQ) to $93 from $92 and keeps an Overweight rating on the shares following Q3 results that the firm says “showcased strong revenue growth momentum.” The transformation of the business into higher quality, more durable revenue streams underway with 10% solutions growth and 8% ARR growth in Q3, the analyst tells investors in a post-earnings note.